Back to Rankings

SOPH

SOPHiA GENETICSC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
SOPH vs peer average
45/100
SOPH vs. peer average (C vs. C)
Grade spread
A 2 · B 1 · C 5 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GH is the first available peer comparator.

Guardant Health remains the cleanest public overlap for SOPHiA's liquid-biopsy ambitions, but GH is much larger and more scaled, so it works better as a strategic benchmark than a tight valuation comp.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGHGuardant Health
SOPH
SOPHiA GENETICS
GH
Guardant Health
Grade
C
C
Momentum
71
96
Value
37
37
Sentiment
55
39
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs GH

SOPH / GH
Grade Position
In line
SOPH vs. peer average (C vs. C)
45/100
Momentum
71
GH
Value
37
SOPH
Sentiment
55
SOPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs SOPH
1
GH
GH
C
60/100
Even
2
MYGN
MYGN
A
100/100
-2
3
TOI
Oncology Institute Inc Common
D
40/100
+1
4
NPCE
NeuroPace Inc Common
D
40/100
+1
5
FLGT
Fulgent Genetics Inc Common
C
60/100
Even
GH is the first peer returned for this comparison set.